Interrupting Fibrosis: Targeting LPA and LPA1 in Pulmonary Fibrosis

In this APAPP podcast, Corinne Young, MSN, FNP-C, FCCP, is joined by Jessica Glennie, NP, of the Cleveland Clinic Interstitial Lung Disease Center, for a practical discussion on pulmonary fibrosis and the emerging LPA/LPA1 receptor pathway. The episode reviews the differences between idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF), the clinical burden these conditions place on patients, and the biological processes that contribute to progressive lung scarring. Cor...